CNO Financial Group (CNO) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Operating earnings per diluted share rose 45% year-over-year in Q2 2026, prompting an 8% increase in full-year guidance to $4.60–$4.80.
Achieved 16 consecutive quarters of insurance sales growth and 14 consecutive quarters of producing agent count growth.
Returned $77 million to shareholders in Q2, including $60 million in share repurchases, and increased the quarterly dividend.
Completed exit from the Worksite Division fee services business, expected to increase annual pre-tax income by $20 million.
TechMod technology modernization initiative continued, with $23.4 million in related expenses in the first half of 2026.
Financial highlights
Operating EPS was $1.26 in Q2 2026, up from $0.87 in Q2 2025.
Net income for Q2 2026 was $125.9 million, up from $91.8 million in Q2 2025.
Book value per diluted share (excluding AOCI) was $39.92, up 5% year-over-year.
Net investment income increased to $411.9 million in Q2 2026, marking the 11th consecutive quarter of growth.
Operating ROE was 14.1% (13.1% excluding significant items) on a trailing 12-month basis.
Outlook and guidance
Full-year operating EPS guidance raised to $4.60–$4.80, up from $4.25–$4.45, an 8% increase at the midpoint.
Expense ratio guidance narrowed to 18.8%–19.0% for 2026.
Effective tax rate assumption lowered to approximately 21.5%.
Free cash flow expected in the range of $200–$250 million; RBC ratio targeted at 360%–390%.
2026 operating ROE expected to exceed the previous 12% target, with new targets to be set in 2027.
Latest events from CNO Financial Group
- All proposals passed and strong financial growth highlighted, with focus on future ROE gains.CNO
AGM 2026 - Operating EPS up 33%, net income up, and premiums up 11% with strong capital and outlook.CNO
Q1 2026 - Record financial performance, strong governance, and enhanced shareholder returns highlighted.CNO
Proxy filing - Annual meeting covers director elections, executive pay, auditor ratification, and ESG efforts.CNO
Proxy filing - Record new annualized premiums and 11% EPS growth drove robust 2025 results.CNO
Q4 2025 - EPS up 26% with record annuity sales, raised 2024 guidance, and strong capital returns.CNO
Q3 2024 - Growth momentum driven by middle market focus, agent productivity, and operational efficiency.CNO
2024 KBW Insurance Conference - Operating EPS up 94%, guidance raised, and sales and investment income surged in Q2 2024.CNO
Q2 2024 - Record sales, earnings growth, and capital returns drive strong 2024 results and 2025 outlook.CNO
Q4 2024